Trial · NCT07061743
Activity Management Training in Low Back Pain
NCT07061743, Not applicable, Not yet recruiting, Çankırı Karatekin University
3 sourcestrials-2026-11-12-0.4.0
Download JSON
Cite this record
ConductScience Library. Activity Management Training in Low Back Pain. Trials, record NCT07061743. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07061743
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Activity Management Training in Low Back Pain
- NCT number
- NCT07061743
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 34 participants, estimated
- Lead sponsor
- Çankırı Karatekin University
- Conditions
- Low Back Pain
- Interventions
- activity management training
- First posted
- 2025-07-11
- Last updated
- 2025-07-11
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Canadian Occupational Performance Measure (COPM) | From enrollment to the end of treatment at 6 weeks | The COPM is used to assess individuals' activity performance and satisfaction levels. In this assessment scale, the problems encountered by individuals in the field of activity performance are determined through a semi-structured interview. Individuals evaluate their activity performance problems with their own performance and satisfaction scores. In the first step, individuals are asked to identify the problems in the areas of self-care, productivity and leisure time that they do, want to do or have difficulty in doing in their routine. In the second step, individuals are asked to assign an importance value between 1 and 10 to each of these activities. In the third step, individuals are asked to select up to 5 activities that are most important for them and to give performance and satisfaction scores between 1 and 10 for each activity. The performance and satisfaction scores are totalled and divided by the number of activities to obtain performance and satisfaction scores. |
| Secondary | Body Awareness Questionnaire | From enrollment to the end of treatment at 6 weeks" | The body awareness of the participants will be evaluated with the Body Awareness Questionnaire (BAQ) developed by Shields (31). The Turkish validity and reliability of the questionnaire was conducted by Karaca (2017). The questionnaire consists of four subscales (Note Changes in Response or Body Process, Predict Body Response, Onset of Illness, and Sleep-Wake Cycle) and 18 questions in total. The questionnaire is scored on a 7-point Likert scale ranging from 'Not true for me' (1) to 'Completely true for me' (7). |
| Secondary | Pain Activity Patterns Scale (PAPS) | From enrollment to the end of treatment at 6 weeks | The PAPS is a scale that determines the changing activity patterns in individuals with chronic pain in 3 subgroups as avoidance, excessive avoidance and regularisation. It was developed by Cane et al. in Canada. The AAPS consists of 3 subgroups, including avoidance, excessive avoidance, and regularisation, and a total of 30 questions, 10 for each subgroup. In the scale, individuals with chronic pain are asked to answer questions about how they perform activities of daily living. In answering the questions in the scale, a 5-point Likert scoring system is used, 0-never, 2-sometimes, 4-always. In the calculation of the scale score, separate score calculations are made for the subgroups of avoidance, overdoing, and regularisation. The total scores calculated for the subgroups vary between 0-40 points separately. Within these 3 subgroups, the subgroup with the highest score by the patient is determined and it is determined which subgroup the participant adopts in activities of daily living |
| Secondary | Loewenstein Occupational Therapy Cognitive Assessment (LOTCA) | From enrollment to the end of treatment at 6 weeks | The Loewenstein Occupational Therapy Cognitive Assessment (LOTCA) will be used in the study to evaluate the basic cognitive skills of individuals. The test consists of 22 items, including 2 items of orientation, 6 items of visual-spatial perception, 7 items of visual-motor organisation, 6 items of thinking skills, and 1 item of attention. The content of the test (36): Orientation: 1. Time orientation 2. Place orientation Visual perception: 1. object recognition 2. shape recognition 3. overlapping figures 4. object invariance 5. spatial perception 6. praxis Visual-motor organisation: 1. Geometric shape copying 2. Two-dimensional model 3. Pegboard construction 4. Coloured block design 5. Plain block design 35 6. Jigsaw puzzle 7. Clock drawing Thinking Skills: 1. Categorisation 2. Risca Object Classification I - structured (Risca Object Classification- ROC I) 3. Riska Object Classification II - unstructured (ROC II) 4. Picture Sorting A 5. Picture Sorting B 6. Geometric Sorting Attention |
| Secondary | Stroop test | From enrollment to the end of treatment at 6 weeks | The Stroop Test is a neuropsychological test that reflects frontal region activity. It measures the brain's ability to direct attention, conceptual flexibility and mental processing speed. In the first stage of the Stroop attention test, people are presented with the names of colours and asked to read these colours quickly. For example, no matter what colour the font is, it will be read as 'red'. In the second step, they are asked to quickly say what colour the dot clusters printed through ink are. For example, if the word 'red' is written in yellow font, they should say "yellow" instead of 'red'. In the final stage of the test, the third stage, the participants are asked to say the words written in a different colour than the name of the colour as fast as possible in a loud voice. For example, the word 'blue' is written in red or black. As a result of these experiments, the Stroop effect occurs. When it was investigated with imaging techniques where the Stroop effect affects the hum |
| Secondary | Cognitive Status Scale | From enrollment to the end of treatment at 6 weeks | It was developed by Broadbent et al. to assess cognitive failures that occur in daily life. Failures in perception, memory, and motor functions are assessed with 25 questions. Each question is scored between 0 (never) and 4 (very often) in the scale consisting of questions such as 'Do you ever find yourself accidentally hiding what you should throw away and throwing away what you should keep?', 'Do you ever forget people's names?', 'Do you drop things?'. The total score ranges from 0-100, with a higher score indicating an increased level of cognitive failure. The validity and reliability study of the Turkish version of the scale was conducted by Ekici et al. |
| Secondary | Fatigue Severity Scale | From enrollment to the end of treatment at 6 weeks | The scale was developed by Krup et al. (1989), and its Turkish validity and reliability were examined by Armutlu et al. (2007). The scale has 9 questions and one dimension. The individual indicates the level of agreement with the items in the scale by choosing a number from 1 (strongly disagree) to 7 (strongly agree). A total score of 9-63 can be obtained from the scale. A total score of 36 or more indicates severe fatigue |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 42876320 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Clock Drawing Task | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07061743
GET https://conductscience.org/api/trials/v1/NCT07061743/registered